Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Apixaban is effective and safe in
Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients after Laparoscopic
Splenectomy and Azygoportal Disconnection